These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34585151)

  • 41. Single crossover-mediated targeted nucleotide substitution and knock-in strategies with CRISPR/Cas9 system in the rice blast fungus.
    Yamato T; Handa A; Arazoe T; Kuroki M; Nozaka A; Kamakura T; Ohsato S; Arie T; Kuwata S
    Sci Rep; 2019 May; 9(1):7427. PubMed ID: 31092866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of knock-in cynomolgus monkey via CRISPR/Cas9 editing.
    Yao X; Liu Z; Wang X; Wang Y; Nie YH; Lai L; Sun R; Shi L; Sun Q; Yang H
    Cell Res; 2018 Mar; 28(3):379-382. PubMed ID: 29327726
    [No Abstract]   [Full Text] [Related]  

  • 43. CRISPR/Cas9 Mediated GFP Knock-in at the MAP1LC3B Locus in 293FT Cells Is Better for Bona Fide Monitoring Cellular Autophagy.
    Wu Z; Zhao J; Qiu M; Mi Z; Meng M; Guo Y; Wang H; Yuan Z
    Biotechnol J; 2018 Nov; 13(11):e1700674. PubMed ID: 29673078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation and validation of
    Martens YA; Xu S; Tait R; Li G; Zhao XC; Lu W; Liu CC; Kanekiyo T; Bu G; Zhao J
    STAR Protoc; 2021 Jun; 2(2):100571. PubMed ID: 34151296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Marker-free carotenoid-enriched rice generated through targeted gene insertion using CRISPR-Cas9.
    Dong OX; Yu S; Jain R; Zhang N; Duong PQ; Butler C; Li Y; Lipzen A; Martin JA; Barry KW; Schmutz J; Tian L; Ronald PC
    Nat Commun; 2020 Mar; 11(1):1178. PubMed ID: 32132530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome editing in the mammalian brain using the CRISPR-Cas system.
    Nishiyama J
    Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From DNA break repair pathways to CRISPR/Cas-mediated gene knock-in methods.
    Rezazade Bazaz M; Dehghani H
    Life Sci; 2022 Apr; 295():120409. PubMed ID: 35182556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of Pax6-IRES-EGFP knock-in mouse via the cloning-free CRISPR/Cas9 system to reliably visualize neurodevelopmental dynamics.
    Inoue YU; Morimoto Y; Hoshino M; Inoue T
    Neurosci Res; 2018 Jul; 132():1-7. PubMed ID: 29391173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An efficient and versatile CRISPR-Cas9 system for genetic manipulation of multi-drug resistant
    McConville TH; Giddins MJ; Uhlemann AC
    STAR Protoc; 2021 Mar; 2(1):100373. PubMed ID: 33733242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9.
    Prykhozhij SV; Fuller C; Steele SL; Veinotte CJ; Razaghi B; Robitaille JM; McMaster CR; Shlien A; Malkin D; Berman JN
    Nucleic Acids Res; 2018 Sep; 46(17):e102. PubMed ID: 29905858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient generation of a CYP3A4-T2A-luciferase knock-in HepaRG subclone and its optimized differentiation.
    Zuo Q; Xu W; Wan Y; Feng D; He C; Lin C; Huang D; Chen F; Han L; Sun Q; Chen D; Du H; Huang L
    Biomed Pharmacother; 2022 Aug; 152():113243. PubMed ID: 35687910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-temperature incubation improves both knock-in and knock-down efficiencies by the CRISPR/Cas9 system in Xenopus laevis as revealed by quantitative analysis.
    Kato S; Fukazawa T; Kubo T
    Biochem Biophys Res Commun; 2021 Mar; 543():50-55. PubMed ID: 33515912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in
    Wang Y; Wang Z; Ji Q
    STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.
    Shao M; Xu TR; Chen CS
    Dongwuxue Yanjiu; 2016 Jul; 37(4):191-204. PubMed ID: 27469250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stem Cell-Based Disease Modeling and Cell Therapy.
    Bai X
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR/Cas9 mediated GFP-human dentin matrix protein 1 (DMP1) promoter knock-in at the ROSA26 locus in mesenchymal stem cell for monitoring osteoblast differentiation.
    Shahabipour F; Oskuee RK; Shokrgozar MA; Naderi-Meshkin H; Goshayeshi L; Bonakdar S
    J Gene Med; 2020 Dec; 22(12):e3288. PubMed ID: 33047833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protocol for Genome Editing to Produce Multiple Mutants in Wheat.
    Abe F; Ishida Y; Hisano H; Endo M; Komari T; Toki S; Sato K
    STAR Protoc; 2020 Sep; 1(2):100053. PubMed ID: 33111098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
    Zheng X; Cairns T; Zheng P; Meyer V; Sun J
    STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in CRISPR/Cas9-mediated knock-ins in mammalian cells.
    Banan M
    J Biotechnol; 2020 Jan; 308():1-9. PubMed ID: 31751596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome Editing of Silkworms.
    Tsubota T; Sezutsu H
    Methods Mol Biol; 2017; 1630():205-218. PubMed ID: 28643261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.